SCM
EW icon

Sone Capital Management’s Edwards Lifesciences EW Stock Holding History

Sone Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-176,039
Closed -$14.1M – 115
2026
Q1 		$14.1M Buy
176,039
+150,984
+603% +$12.4M 1.18% 32
2025
Q4 		$2.14M Sell
25,055
-6,848
-21% -$562K 0.17% 92
2025
Q3 		$2.48M Buy
31,903
+28,194
+760% +$2.2M 0.21% 92
2025
Q2 		$290K Buy
+3,709
New +$277K 0.03% 97

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sone Capital Management's EW Position: Q2 2026 in Review

Sone Capital Management sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 176,039 shares — an estimated $14.1M sold.

Sone Capital Management first reported a position in EW in Q2 2025 and held it in 4 quarters. The position peaked at $14.1M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Sone Capital Management reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Sone Capital Management sold 176,039 Edwards Lifesciences shares in Q2 2026, an estimated $14.1M.
  • Sone Capital Management first reported a position in Edwards Lifesciences in Q2 2025 and held it in 4 quarters.
  • Sone Capital Management's Edwards Lifesciences position peaked at $14.1M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Sone Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.